A large, international trial has found intermittent androgen deprivation therapy (ADT) is not equivalent to continuous ADT.
John Schieszer reports in today’s Medical Minute on a study that included 1,535 patients with metastatic prostate cancer and followed for a median of 10 years.
Next post in The Medical Minute
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.